OptiBiotix Health PLC saw its shares rise 13.5% to 5.68p after announcing a June event in London to showcase its SweetBiotix healthy sugar substitute products to investors. The company achieved a breakthrough in November 2025 by improving the manufacturing process, resulting in higher yields of a purer, more concentrated, and better-tasting product with lower costs. The event will allow shareholders and potential investors to sample the product and learn about the commercial progress and market plans for SweetBiotix's first and second-generation products. This development highlights OptiBiotix's focus on gut microbiome health and reducing hunger and food cravings.
In 2026, a new wave of immunotherapy treatments is advancing against historically resistant solid tumors such as prostate and pancreatic cancer. GT Biopharma initiated a Phase 1 trial for GTB-5550, a natural killer cell engager targeting seven solid ...
US stock futures gained following a mixed market close and President Trump's approval of Nvidia's H200 AI chip sales to Chinese firms, although China has halted deliveries. Economic data showed a 0.5% rise in April retail sales and a slight increase ...
Sumitomo Forestry has finalized its acquisition of Tri Pointe Homes for $47 per share, making Tri Pointe a wholly owned subsidiary and delisting it from the NYSE. This deal expands Sumitomo Forestry's U.S. homebuilding presence to 18 states, deliveri...
Verde Resources Inc. announced its invitation to the GenZero Climate Summit 2026 in Singapore, a key event focused on advancing net zero solutions. The company aims to expand its presence in Singapore and Southeast Asia, leveraging its newly establis...
Boeing shares rose following Treasury Secretary Scott Bessent's indication of significant aircraft orders from China during President Trump's meeting with Chinese President Xi Jinping. The U.S.-China tariff dispute had previously halted Boeing delive...
